{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/benzodiazepine-z-drug-withdrawal/background-information/definition/","result":{"pageContext":{"chapter":{"id":"24a95463-c4af-5572-b06f-acf2f15c47d1","slug":"definition","fullItemName":"Definition","depth":2,"htmlHeader":"<!-- begin field 59739168-563f-45ab-bd7f-452af42ca220 --><h2>What are benzodiazepines and z-drugs?</h2><!-- end field 59739168-563f-45ab-bd7f-452af42ca220 -->","summary":"","htmlStringContent":"<!-- begin item 9b52ef03-d7bf-4e30-8a63-beadb6adebda --><!-- begin field 6444b764-bb85-41b4-ad54-0baeb63b1206 --><ul><li><strong>Benzodiazepines </strong>are gamma-aminobutyric acid (GABA) receptor agonists which have hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties. The British National Formulary groups benzodiazepines into hypnotics and anxiolytics.<ul><li><strong>Hypnotics </strong>are used for short term treatment of insomnia and include nitrazepam and flurazepam (which are longer-acting) and loprazolam, lormetazepam, and temazepam (which are short-acting and therefore have little or no next-day 'hangover' effect).</li><li><strong>Anxiolytics </strong>are effective in alleviating anxiety states and include diazepam, alprazolam, chlordiazepoxide, and clobazam (which have a sustained action), and lorazepam and oxazepam (which are shorter acting).<ul><li>Some anxiolytics may have other indications, for example, diazepam can also be prescribed to treat muscle spasm, and as an adjunct in acute alcohol withdrawal, status epilepticus, and insomnia, and oxazepam and lorazepam can be prescribed for insomnia.</li></ul></li></ul></li><li><strong>Z-drugs </strong>are non-benzodiazepine hypnotics, developed with the intention of overcoming some of the adverse effects of benzodiazepines (such as next-day sedation, dependence and withdrawal), but there is no firm evidence of differences in the effect of z-drugs and shorter-acting benzodiazepines.<ul><li>The two z-drugs available in the UK are zolpidem, and zopiclone.</li><li>Like benzodiazepines, z-drugs are GABA receptor agonists.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">National Addiction Centre et al, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">BNF 76, 2018</a>]</p><!-- end field 6444b764-bb85-41b4-ad54-0baeb63b1206 --><!-- end item 9b52ef03-d7bf-4e30-8a63-beadb6adebda -->","topic":{"id":"e3f1abb8-a968-53c3-bc6a-12e1b2886ed2","topicId":"35151ccb-5966-4e29-97a4-191f3f2aef6a","topicName":"Benzodiazepine and z-drug withdrawal","slug":"benzodiazepine-z-drug-withdrawal","lastRevised":"Last revised in January 2019","chapters":[{"id":"ddeb227b-ec5e-5a69-b033-23d16e492302","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ca1d0037-207c-5656-8c1a-64eb8f8a6adf","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"4f9475f8-9d93-5b3d-9cc7-66f08d975494","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"33c4d415-a5bf-586c-af94-95833f29167f","slug":"changes","fullItemName":"Changes"},{"id":"814181c9-c71c-54f0-a9f2-a7b2a5f73459","slug":"update","fullItemName":"Update"}]},{"id":"2237f5ce-b47f-5f59-80d4-2098a2fafae1","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"14f4d723-2346-5509-b69f-ec1690c54f89","slug":"goals","fullItemName":"Goals"},{"id":"978d3882-5b77-58d0-9081-5f1879a2e244","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"df6950b2-9910-5c3e-9f7e-a89c359ba5cf","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f78c4bb6-5d1b-516c-acb6-5a8a6add79ec","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1d88ca0e-4d2b-56ae-9602-a213d4c8767e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"00453e06-07ba-5d13-a4f0-dfd3b6e7dfa4","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"058ea4e2-b85f-5dbf-885b-f3a39f06d48c","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"24a95463-c4af-5572-b06f-acf2f15c47d1","slug":"definition","fullItemName":"Definition"},{"id":"fbb9e10e-ed3c-51d5-b3fa-e2d482b83413","slug":"prevalance","fullItemName":"Prevalance"},{"id":"32dfcd69-3d5d-5897-bd8f-cee84b53b670","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"d110deb7-70d0-5c76-8606-a9af49e97f91","slug":"complications","fullItemName":"Complications"},{"id":"c26626ad-6167-542c-98fe-a2ff03221e61","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"a846d324-cab9-57dd-a619-3bf18b540356","fullItemName":"Management","slug":"management","subChapters":[{"id":"80278306-0d51-5a46-abdb-638c41fd825d","slug":"benzodiazepine-z-drug-withdrawal","fullItemName":"Scenario: Benzodiazepine and z-drug withdrawal"}]},{"id":"b14f0631-9202-58fa-a823-a1f92f05ac08","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"22b2c65a-e4c1-5d8f-9260-f639540d94cb","slug":"diazepam","fullItemName":"Diazepam"}]},{"id":"3833e4c8-dbff-59bf-92ae-bd1c772444bb","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"d4659376-3ee7-5273-9fe9-08f5ce86d7d8","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9bd84543-e92f-541d-80e5-17f0b36fcb90","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"d3ade608-7d7c-5174-9cad-8cecde797cd1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3e7141fe-bc43-5b07-81c4-1fb82ca82b2c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"5c9aad6e-7321-5cc2-bad0-677e761afc6e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7a323840-12e0-545e-87de-461171f81997","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"351aac8e-ed32-587e-88b8-27ee3fa69f10","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"058ea4e2-b85f-5dbf-885b-f3a39f06d48c","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}